NL-OMON45734
Completed
Not Applicable
Genetic screening in Parkinson*s Disease in order to identify patients who can participate in clinical trials with new targeted therapies - GBA1 and LRRK2 screening
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- movement disorder
- Sponsor
- Centre for Human Drug Research
- Enrollment
- 1000
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Signed informed consent prior to any study\-mandated procedure;
- •2\. Diagnosis of Parkinson\*s Disease, diagnosed by a neurologist;
- •3\. Has the ability to communicate well with the Investigator in the Dutch language and willing to comply with the study restrictions.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study to investigate mutations in the GBA1 and LRRK2 genes in Parkinson’s Disease patients.Parkinson’s DiseaseNL-OMON23101CHDR1,000
Not yet recruiting
Not Applicable
Genetic screening in Parkinson*s disease patients to identify GBA1 mutation carriers for future clinical trials.Parkinson's disease10028037NL-OMON56348Vanqua Bio Inc.1,000
Active, not recruiting
Not Applicable
Genetic screening for GBA1 in Parkinson’s disease patientsParkinson's disease, ParkinsonismNervous System DiseasesISRCTN99451262Vanqua Bio Inc.1,000
Not yet recruiting
Not Applicable
Search for Genetic Factors in Parkinson's Disease - IINL-OMON51549Erasmus MC, Universitair Medisch Centrum Rotterdam700
Completed
Not Applicable
Search for Genetic Factors in Parkinson*s diseaseParkinsonismParkinson's Disease1002929910028037NL-OMON37785Erasmus MC, Universitair Medisch Centrum Rotterdam700